Company MYND Life Sciences Inc. OTC Markets
Equities
MYNDF
CA62857B1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0125 USD | 0.00% | 0.00% | -59.94% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
Founder | 65 | 18-07-05 | |
Lih-Ming Tam
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | 22-03-08 | |
Iryna Saranchova
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 18-07-05 | |
Lyle Oberg
FOU | Founder | 63 | 18-07-05 |
John Campbell
CEO | Chief Executive Officer | 53 | 20-11-25 |
Director/Board Member | 61 | 20-11-25 | |
Scott Nicoll
BRD | Director/Board Member | - | 21-10-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,817,182 | 9,785,852 ( 20.47 %) | 0 | 20.47 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- MYND Stock
- MYNDF Stock
- Company MYND Life Sciences Inc.